Investigational Site Number 040002

Vienna A-1090

0 studies enrolling now · 6 studies all time

What they study most

Acute Coronary Syndrome, Ankylosing Spondylitis, Atherosclerotic Cardiovascular Disease, Diabetes Mellitus, Type 2, Multiple Sclerosis, Rheumatoid Arthritis

Studies at this site

• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed
• Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis — Completed
• Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients — Completed
• Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients — Completed
• Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy — Completed
• Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure — Completed